21 results
As a follow up to a previously uploaded infographic delineating indications for the widely-used induction agents
infographic delineating indications ... induction agents in anesthesia ... #clinical #management ... #anesthesia #anesthesiology ... #sideeffects #treatment
Induction agents used in anesthesia play a key role in the eventual sedation of the patient,
agents used in anesthesia ... #clinical #management ... anesthesiology #anesthesia ... reference.medscape.com/drug ... Effects, Dosages, Treatment
A quick infographic describing some of the common reversal agents used by anesthesiologists, their mechanism of
agents #management #anesthesia ... anesthesiology #treatment ... #medications ... and critical care ... revolutionary drug
Peri-operative Hyperthermia - Guidelines for Crises in Anaesthesia
If prolonged or ≥ 39 C this is a
39 C this is a clinical ... Treatment depends ... production • Actively ... anaphylaxis (→ 3-1) Drug ... Anesthesiology #Anesthesia
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... #Tuberculosis #ActiveTB ... Therapy #regimens #medications ... IDSA #Guidelines #Treatment
Approach to Undifferentiated Shock - OnePager Summary
Shock occurs when there is inadequate blood flow (CO) &
essential to determine treatment ... CCB, BB, BRASH syndrome ... Cardiac Tamponade, Pulmonary ... thyrotoxicosis), Medications ... (anesthesia, sedation
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... characteristic features Clinical ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... characteristic features Clinical ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
Treatment Options for Helicobacter Pylori and Peptic Ulcer Disease

Active Helicobacter pylori—associated ulcer
1. Treat with anti—H pylori
Ulcer Disease Active ... Active ulcer not ... Zollinger-EIIison syndrome ... the preferred drugs ... #Pharmacology #Medications
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
Aplastic Anemia Clinical ... Dyskeratosis congenita • Drugs ... - Cytotoxic drugs ... - Antithyroid medications ... aplastic anemia Treatment